For citations:
Fitilev S.B., Glukhov Yu.F., Lukyanov S.V., Vozzhaev A.V., Shkrebniova I.I., Kazey V.I., Bondareva I.B. Safety, pharmacokinetics and pharmacodynamics of an original glycoprotein IIb/IIIa inhibitor in healthy volunteers: results of the clinical trial. Cardiovascular Therapy and Prevention. 2022;21(3):3033. (In Russ.) https://doi.org/10.15829/1728-8800-2022-3033